Atlas Trials

Efficacy and Tolerance of THC 25: CBD 25 in Patients With Severe Pruritus: a Multicenter, Double-blind, Randomized, Placebo-controlled Study

Clinical trial NCT06435299 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06435299
Sponsor
University Hospital, Brest
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Pruritus
Start date
2027-01-01
Primary completion
2029-03-01
Enrollment
218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.